Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson’s disease and sleep disorders: a randomized, double-blind trial

[1] Oerlemans WG(2002)The prevalence of sleep disorders in patients with Parkinson’s disease. A self-reported, community-based survey Sleep medicine 3 147-9

[2] de Weerd AW(2014)Evaluation of sleep disorders in Parkinson’s disease: a comparison between physician diagnosis and self-administered questionnaires J Med Assoc Thai= Chotmaihet thangphaet 97 S68-77

[3] Jongwanasiri S(2016)Circadian system - a novel diagnostic and therapeutic target in Parkinson’s disease? Mov Disord: Off J Mov Disord Soc 31 260-269

[4] Prayoonwiwat N(2014)Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease JAMA Neurol 71 463-469

[5] Pisarnpong A(2020)Multiple comorbid sleep disorders adversely affect quality of life in Parkinson’s disease patients npj Parkinsons Dis 6 25-120

[6] Srivanitchapoom P(2016)A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder Sleep Med 21 114-104

[7] Chotinaiwattarakul W(2017)Twenty years after: another case report of melatonin effects on REM sleep behavior disorder, using serial dopamine transporter imaging Neuropsychobiology 76 100-86

[8] Videnovic A(2019)Clonazepam for probable REM sleep behavior disorder in Parkinson’s disease: a randomized placebo-controlled trial J Neurol Sci 401 81-54

[9] Willis GL(2020)Prolonged-release melatonin in Parkinson’s disease patients with a poor sleep quality: a randomized trial Parkinsonism Relat Disord 75 50-349

[10] Videnovic A(2020)Melatonin for rapid eye movement sleep behavior disorder in Parkinson’s disease: a randomised controlled trial Mov Disord: Off J Mov Disord Soc 35 344-198

[1] Oerlemans WG(2002)The prevalence of sleep disorders in patients with Parkinson’s disease. A self-reported, community-based survey Sleep medicine 3 147-9

[2] de Weerd AW(2014)Evaluation of sleep disorders in Parkinson’s disease: a comparison between physician diagnosis and self-administered questionnaires J Med Assoc Thai= Chotmaihet thangphaet 97 S68-77

[3] Jongwanasiri S(2016)Circadian system - a novel diagnostic and therapeutic target in Parkinson’s disease? Mov Disord: Off J Mov Disord Soc 31 260-269

[4] Prayoonwiwat N(2014)Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease JAMA Neurol 71 463-469

[5] Pisarnpong A(2020)Multiple comorbid sleep disorders adversely affect quality of life in Parkinson’s disease patients npj Parkinsons Dis 6 25-120

[6] Srivanitchapoom P(2016)A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder Sleep Med 21 114-104

[7] Chotinaiwattarakul W(2017)Twenty years after: another case report of melatonin effects on REM sleep behavior disorder, using serial dopamine transporter imaging Neuropsychobiology 76 100-86

[8] Videnovic A(2019)Clonazepam for probable REM sleep behavior disorder in Parkinson’s disease: a randomized placebo-controlled trial J Neurol Sci 401 81-54

[9] Willis GL(2020)Prolonged-release melatonin in Parkinson’s disease patients with a poor sleep quality: a randomized trial Parkinsonism Relat Disord 75 50-349

[10] Videnovic A(2020)Melatonin for rapid eye movement sleep behavior disorder in Parkinson’s disease: a randomised controlled trial Mov Disord: Off J Mov Disord Soc 35 344-198